<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Recent studies suggest that <z:mp ids='MP_0001794'>bacterial</z:mp> endotoxins may be associated with various <z:hpo ids='HP_0011010'>chronic</z:hpo> diseases, including colorectal <z:mpath ids='MPATH_270'>adenomas</z:mpath> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Given the evidence linking <z:mp ids='MP_0001845'>inflammation</z:mp> and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, we sought to determine if plasma endotoxin concentrations are associated with indicators of systemic or local <z:mp ids='MP_0001845'>inflammation</z:mp> and colorectal <z:mpath ids='MPATH_270'>adenomas</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: This cross-sectional study consisted of participants who underwent screening colonoscopies and included <z:mpath ids='MPATH_270'>adenoma</z:mpath> cases (n=138) and non-<z:mpath ids='MPATH_270'>adenoma</z:mpath> controls (n=324) </plain></SENT>
<SENT sid="3" pm="."><plain>Plasma concentrations of endotoxin were measured with Limulus Amebocyte Lysate (LAL) assay </plain></SENT>
<SENT sid="4" pm="."><plain>We quantified concentrations of inflammatory cytokines, interleukin-4 (IL-4), IL-6, IL-8, IL-10, IL-12, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha (TNF-α), and interferon-γ (IFN-γ) in plasma by ELISA and <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression levels in rectal mucosal biopsies by quantitative RT-PCR </plain></SENT>
<SENT sid="5" pm="."><plain>Interleukin-17 was evaluated only in the rectal mucosa </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Compared to subjects with low plasma endotoxin concentrations, those with higher concentrations were more likely to have <z:mpath ids='MPATH_270'>adenomas</z:mpath> (OR 1.4, 95% CI 1.0-2.1) </plain></SENT>
<SENT sid="7" pm="."><plain>Among subjects with <z:mpath ids='MPATH_270'>adenomas</z:mpath>, those with villous histology were more likely to have higher endotoxin concentrations (5.4 vs. 4.1EU/mL, p=0.05) and lower plasma IFN-γ (0 vs. 1.64 pg/mL, p=0.02) compared to those with only tubular <z:mpath ids='MPATH_270'>adenomas</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>Cases showed a trend of having higher plasma TNF-α levels than controls (p=0.06), but none of the other plasma or rectal mucosal cytokine levels differed between cases and controls </plain></SENT>
<SENT sid="9" pm="."><plain>Elevated mucosal IL-12 levels were associated with having multiple <z:mpath ids='MPATH_270'>adenomas</z:mpath> (p=0.04) </plain></SENT>
<SENT sid="10" pm="."><plain>Higher concentrations of plasma endotoxin predicted increased plasma IL-12 levels (OR 1.5, 95% CI 1.0-2.2) and rectal mucosal IL-12 (OR 1.9, 95% CI 1.0-3.7) and IL-17 gene expression (OR 2.2, 95% CI 1.0-4.6) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: These findings suggest that interactions between elevated plasma endotoxin concentrations and inflammatory cytokines may be relevant to the development of colorectal <z:mpath ids='MPATH_270'>adenomas</z:mpath> </plain></SENT>
</text></document>